A multidisciplinary intervention to improve postoperative antithrombotic therapy after urgent coronary artery bypass-grafts.

IF 1.1 Q4 PHARMACOLOGY & PHARMACY
Alma Feka, Mario Verdugo-Marchese, Sarah Hugelshofer, Stéphane Guerrier, Nancy Perrottet, Matthias Kirsch, Farshid Sadeghipour, Ziyad Gunga
{"title":"A multidisciplinary intervention to improve postoperative antithrombotic therapy after urgent coronary artery bypass-grafts.","authors":"Alma Feka, Mario Verdugo-Marchese, Sarah Hugelshofer, Stéphane Guerrier, Nancy Perrottet, Matthias Kirsch, Farshid Sadeghipour, Ziyad Gunga","doi":"10.1016/j.pharma.2025.08.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The objective of this study was to assess whether implementing a protocol could improve adherence to European guidelines on postoperative antithrombotic therapy prescription in patients undergoing coronary artery bypass-grafts surgery (CABG) after acute coronary syndrome (ACS).</p><p><strong>Methods: </strong>We included patients who underwent cardiac surgery between January 2018 and December 2022. The population was divided in two groups, one before (group 1) and one after (group 2) the dissemination of a protocol on postoperative antithrombotic therapy issued by a multidisciplinary collaboration (January 2021) and its subsequent implementation during ward rounds. We analysed the protocol's impact on adherence to European guidelines in terms of antithrombotic therapy at discharge.</p><p><strong>Results: </strong>We included 259 patients, 83.8% were men and the median age was 67 [58; 74] years. At baseline, group 1 (n=152) and group 2 (n=107) had similar demographic characteristics except for smoking status and ACS events. Patients in group 2 had a higher rate of guideline adherence in terms of postoperative antithrombotic therapy (group 1=58.6% vs. group 2=82.2%, P<0.001). Using logistic regression accounting for demographic and temporal factors, the effect of the intervention was positive but not statistically significant. Adherence increased significantly over time, suggesting that the intervention contributed to an overall trend of improved adherence as apart of ongoing quality improvement efforts.</p><p><strong>Conclusion: </strong>Implementing the protocol was associated with a positive effect on guideline adherence for postoperative antithrombotic therapy in ACS patients undergoing CABG. Although the intervention's independent effect was not statistically significant after adjustment, the findings support its role in achieving sustained improvement in adherence over time.</p>","PeriodicalId":8332,"journal":{"name":"Annales pharmaceutiques francaises","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales pharmaceutiques francaises","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.pharma.2025.08.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The objective of this study was to assess whether implementing a protocol could improve adherence to European guidelines on postoperative antithrombotic therapy prescription in patients undergoing coronary artery bypass-grafts surgery (CABG) after acute coronary syndrome (ACS).

Methods: We included patients who underwent cardiac surgery between January 2018 and December 2022. The population was divided in two groups, one before (group 1) and one after (group 2) the dissemination of a protocol on postoperative antithrombotic therapy issued by a multidisciplinary collaboration (January 2021) and its subsequent implementation during ward rounds. We analysed the protocol's impact on adherence to European guidelines in terms of antithrombotic therapy at discharge.

Results: We included 259 patients, 83.8% were men and the median age was 67 [58; 74] years. At baseline, group 1 (n=152) and group 2 (n=107) had similar demographic characteristics except for smoking status and ACS events. Patients in group 2 had a higher rate of guideline adherence in terms of postoperative antithrombotic therapy (group 1=58.6% vs. group 2=82.2%, P<0.001). Using logistic regression accounting for demographic and temporal factors, the effect of the intervention was positive but not statistically significant. Adherence increased significantly over time, suggesting that the intervention contributed to an overall trend of improved adherence as apart of ongoing quality improvement efforts.

Conclusion: Implementing the protocol was associated with a positive effect on guideline adherence for postoperative antithrombotic therapy in ACS patients undergoing CABG. Although the intervention's independent effect was not statistically significant after adjustment, the findings support its role in achieving sustained improvement in adherence over time.

多学科干预提高紧急冠状动脉旁路移植术后抗血栓治疗。
目的:本研究的目的是评估在急性冠脉综合征(ACS)后接受冠状动脉旁路移植手术(CABG)的患者中,实施一项方案是否可以提高对欧洲术后抗血栓治疗处方指南的依从性。方法:我们纳入了2018年1月至2022年12月期间接受心脏手术的患者。人群分为两组,一组是在多学科合作发布的术后抗血栓治疗方案(2021年1月)传播之前(1组),一组是在之后(2组),随后在查房期间实施。我们分析了该方案在出院时抗血栓治疗方面对遵守欧洲指南的影响。结果:我们纳入259例患者,83.8%为男性,中位年龄67岁[58;74]岁。在基线时,组1 (n = 152)和组2 (n = 107)除了吸烟状况和ACS事件外具有相似的人口统计学特征。在术后抗血栓治疗方面,组2患者有更高的指南依从率(组1 = 58.6% vs组2 = 82.2%,p < 0.001)。采用logistic回归计算人口统计学和时间因素,干预的效果是积极的,但没有统计学意义。随着时间的推移,依从性显著增加,表明干预有助于改善依从性的总体趋势,作为持续质量改进工作的一部分。结论:实施该方案对ACS行冠脉搭桥患者术后抗血栓治疗指南的依从性有积极影响。虽然调整后干预的独立效果在统计上不显著,但研究结果支持其在长期持续改善依从性方面的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annales pharmaceutiques francaises
Annales pharmaceutiques francaises PHARMACOLOGY & PHARMACY-
CiteScore
1.70
自引率
7.70%
发文量
98
期刊介绍: This journal proposes a scientific information validated and indexed to be informed about the last research works in all the domains interesting the pharmacy. The original works, general reviews, the focusing, the brief notes, subjected by the best academics and the professionals, propose a synthetic approach of the last progress accomplished in the concerned sectors. The thematic Sessions and the – life of the Academy – resume the communications which, presented in front of the national Academy of pharmacy, are in the heart of the current events.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信